Redx to resume RXC004 clinical trial programme

Clinical Research |  News | 0 Comment | 22 Jan, 2019

UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agen...Read more

Abcam, Loulou Foundation enters research collaboration for CDKL5 deficiency disorder

Clinical Research |  News | 0 Comment | 22 Jan, 2019

Abcam, a global innovator in life science reagents and tools, and the Loulou Foundation, a private UK-based foundation d...Read more

TaiwanJ Pharma announces new clinical results on AIH drug

Clinical Research |  News | 0 Comment | 22 Jan, 2019

TaiwanJ Pharmaceuticals, a specialty pharmaceutical company dedicated to the development and commercialization of small ...Read more

Lilly reports results of ANNOUNCE

Clinical Research |  News | 0 Comment | 21 Jan, 2019

Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combinat...Read more

AIVITA gets IND nod for Phase 1B melanoma trial

Clinical Research |  News | 0 Comment | 17 Jan, 2019

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...Read more

United Neuroscience gets positive results from Ph2a trial for Alzheimer's vaccine

Clinical Research |  News | 0 Comment | 17 Jan, 2019

United Neuroscience (UNS), a clinical-stage biotech company pioneering a new class of medicine to treat and prevent brai...Read more

Bridge Bio receives FDA ODD for IPF drug

Clinical Research |  News | 0 Comment | 17 Jan, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant compan...Read more

Immunocore names David Berman as Head of R&D

Clinical Research |  News | 0 Comment | 16 Jan, 2019

Clinical-Stage Biotechnology company, Immunocore has announced David Berman as its new Head of Research and Development....Read more

Innovent announces dosing of patient in a Ph1 clinical trial of Anti-CD47 MAb

Clinical Research |  News | 0 Comment | 16 Jan, 2019

Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has ...Read more

NIH starts clinical trial for FMT

Clinical Research |  News | 0 Comment | 15 Jan, 2019

A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota tr...Read more

UroGen Pharma announces positive results of UGN-101

Clinical Research |  News | 0 Comment | 14 Jan, 2019

A clinical stage pharma company, UroGen Pharma developing treatments to address unmet needs in the field of urology has ...Read more

CellMax, Medigen partner for cell therapy clinical trials

Clinical Research |  News | 0 Comment | 11 Jan, 2019

CellMax Life, a US based diagnostics company with a proprietary technology to detect precancer and cancer cells in blood...Read more

Forbius announces the first patient dosed in a Phase 1 trial of AVID200

Clinical Research |  News | 0 Comment | 09 Jan, 2019

Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...Read more

Immutep collaborates with CYTLIMIC

Clinical Research |  News | 0 Comment | 08 Jan, 2019

Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...Read more

Solasia initiates Phase III programme for PledOx

Clinical Research |  News | 0 Comment | 07 Jan, 2019

Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...Read more

USFDA approves Portola Pharmaceuticals’ Andexxa®

Clinical Research |  News | 0 Comment | 03 Jan, 2019

Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...Read more

Apellis Pharmaceuticals provides update on its Phase 3 program

Clinical Research |  News | 0 Comment | 01 Jan, 2019

Apellis Pharmaceuticals Inc. has provided an update on the status of its Phase 3 program for APL-2 in patients with...Read more

Apellis Pharmaceuticals’ APL-2 receives orphan drug designation from the FDA

Clinical Research |  News | 0 Comment | 01 Jan, 2019

Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...Read more